TSA Orders 1,353 Explosive Trace Detectors

Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Transportation Security Administration (TSA) has placed a delivery order for 1,353 QS-B220 Desktop Explosive Trace Detectors and ancillary supplies. The Delivery Order includes options for TSA to purchase an additional 2,073 QS-B220's within one year of the contract award. The systems will be deployed at multiple airports across the country.

"Implant Sciences has developed an explosive trace detection platform that is highly valued by the security industry. This order is another major milestone for the company and we are proud that our product helps protect the traveling public in the United States. We look forward to continue our working relationship with TSA," said Implant Sciences' CEO, Dr. William McGann.